308 related articles for article (PubMed ID: 9786168)
1. D-amino acid-substituted analogs of corticotropin-releasing hormone (CRH) and urocortin with selective agonist activity at CRH1 and CRH2beta receptors.
Wei ET; Thomas HA; Christian HC; Buckingham JC; Kishimoto T
Peptides; 1998; 19(7):1183-90. PubMed ID: 9786168
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of mouse melanoma cell proliferation by corticotropin-releasing hormone and its analogs.
Carlson KW; Nawy SS; Wei ET; Sadée W; Filov VA; Rezsova VV; Slominski A; Quillan JM
Anticancer Res; 2001; 21(2A):1173-9. PubMed ID: 11396159
[TBL] [Abstract][Full Text] [Related]
3. [D-Pro5]Corticotropin-releasing factor analogs as selective agonists at corticotropin-releasing factor receptors.
Wei ET; Thomas HA; Price JS; Kishimoto T
Eur J Pharmacol; 1996 Jun; 306(1-3):161-4. PubMed ID: 8813628
[TBL] [Abstract][Full Text] [Related]
4. Effect of urocortin on ACTH secretion from rat anterior pituitary in vitro and in vivo: comparison with corticotropin-releasing hormone.
Asaba K; Makino S; Hashimoto K
Brain Res; 1998 Sep; 806(1):95-103. PubMed ID: 9739115
[TBL] [Abstract][Full Text] [Related]
5. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
Vaughan J; Donaldson C; Bittencourt J; Perrin MH; Lewis K; Sutton S; Chan R; Turnbull AV; Lovejoy D; Rivier C
Nature; 1995 Nov; 378(6554):287-92. PubMed ID: 7477349
[TBL] [Abstract][Full Text] [Related]
6. Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats.
Turnbull AV; Vale W; Rivier C
Eur J Pharmacol; 1996 May; 303(3):213-6. PubMed ID: 8813571
[TBL] [Abstract][Full Text] [Related]
7. Effect of urocortin and its interaction with adrenocorticotropin (ACTH) secretagogues on ACTH release.
Ozawa M; Oki Y; Watanabe F; Iino K; Masuzawa M; Iwabuchi M; Yoshimi T
Peptides; 1998; 19(3):513-8. PubMed ID: 9533639
[TBL] [Abstract][Full Text] [Related]
8. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.
Lewis K; Li C; Perrin MH; Blount A; Kunitake K; Donaldson C; Vaughan J; Reyes TM; Gulyas J; Fischer W; Bilezikjian L; Rivier J; Sawchenko PE; Vale WW
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7570-5. PubMed ID: 11416224
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin-releasing hormone receptor expression and functional coupling in neonatal cardiac myocytes and AT-1 cells.
Heldwein KA; Redick DL; Rittenberg MB; Claycomb WC; Stenzel-Poore MP
Endocrinology; 1996 Sep; 137(9):3631-9. PubMed ID: 8756527
[TBL] [Abstract][Full Text] [Related]
10. Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I.
Pedersen WA; Wan R; Zhang P; Mattson MP
J Neurosci; 2002 Jan; 22(2):404-12. PubMed ID: 11784785
[TBL] [Abstract][Full Text] [Related]
11. Urocortin and inflammation: confounding effects of hypotension on measures of inflammation.
Torpy DJ; Webster EL; Zachman EK; Aguilera G; Chrousos GP
Neuroimmunomodulation; 1999; 6(3):182-6. PubMed ID: 10213916
[TBL] [Abstract][Full Text] [Related]
12. Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala.
Bakshi VP; Smith-Roe S; Newman SM; Grigoriadis DE; Kalin NH
J Neurosci; 2002 Apr; 22(7):2926-35. PubMed ID: 11923457
[TBL] [Abstract][Full Text] [Related]
13. Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro.
Leitch IM; Boura AL; Botti C; Read MA; Walters WA; Smith R
J Clin Endocrinol Metab; 1998 Dec; 83(12):4510-3. PubMed ID: 9851801
[TBL] [Abstract][Full Text] [Related]
14. Cloning and characterization of human urocortin.
Donaldson CJ; Sutton SW; Perrin MH; Corrigan AZ; Lewis KA; Rivier JE; Vaughan JM; Vale WW
Endocrinology; 1996 May; 137(5):2167-70. PubMed ID: 8612563
[TBL] [Abstract][Full Text] [Related]
15. Regulation of pituitary corticotropin releasing hormone receptors.
Aguilera G; Rabadan-Diehl C; Nikodemova M
Peptides; 2001 May; 22(5):769-74. PubMed ID: 11337090
[TBL] [Abstract][Full Text] [Related]
16. Characterization of [125I]sauvagine binding to CRH2 receptors: membrane homogenate and autoradiographic studies.
Rominger DH; Rominger CM; Fitzgerald LW; Grzanna R; Largent BL; Zaczek R
J Pharmacol Exp Ther; 1998 Jul; 286(1):459-68. PubMed ID: 9655891
[TBL] [Abstract][Full Text] [Related]
17. Correlation of neuroendocrine and anti-edema activities of alanine-corticotropin-releasing factor analogs.
Wei ET; Thomas HA
Eur J Pharmacol; 1994 Oct; 263(3):319-21. PubMed ID: 7843271
[TBL] [Abstract][Full Text] [Related]
18. Cloning and functional pharmacology of two corticotropin-releasing factor receptors from a teleost fish.
Pohl S; Darlison MG; Clarke WC; Lederis K; Richter D
Eur J Pharmacol; 2001 Nov; 430(2-3):193-202. PubMed ID: 11711031
[TBL] [Abstract][Full Text] [Related]
19. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins.
Grammatopoulos DK; Randeva HS; Levine MA; Katsanou ES; Hillhouse EW
Mol Endocrinol; 2000 Dec; 14(12):2076-91. PubMed ID: 11117536
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors.
Facci L; Stevens DA; Pangallo M; Franceschini D; Skaper SD; Strijbos PJ
Neuropharmacology; 2003 Oct; 45(5):623-36. PubMed ID: 12941376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
